RIDE - Hot Stocks: XLRN merger talks; RIDE downgrade; SPNE COVID woes; GCI refinance; GGPI signs deal with Polestar
Merger activity and corporate guidance provided the key themes for Monday's pre-market trading. Acceleron Pharma (NASDAQ:XLRN) posted gains on reports that it was in talks to be acquired. Meanwhile, SPAC Gores Guggenheim (NASDAQ:GGPI) signed a deal with Polestar to take that company public. On the earnings front, SeaSpine (NASDAQ:SPNE) suffered a pre-market setback. COVID uncertainties undermined its ability to confirm its previous guidance. Elsewhere, Gannett (NYSE:GCI) confirmed its previous revenue forecast and announced a restructuring of some of its debt. The news sent the stock higher in pre-market trading. In other news, Lordstown Motors (NASDAQ:RIDE) encountered some pre-market selling following a bearish note from a Wall Street analyst. Gainers Acceleron Pharma (XLRN) saw buying interest during pre-market action, as takeover discussions sent shares nearly 4% higher. According to Bloomberg, the firm has entered advanced talks with an unnamed big pharma player. The purchase price of the deal would be about
For further details see:
Hot Stocks: XLRN merger talks; RIDE downgrade; SPNE COVID woes; GCI refinance; GGPI signs deal with Polestar